Search

Your search keyword '"Korn, Stephanie"' showing total 418 results

Search Constraints

Start Over You searched for: Author "Korn, Stephanie" Remove constraint Author: "Korn, Stephanie"
418 results on '"Korn, Stephanie"'

Search Results

1. CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD

3. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

10. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

11. German asthma net: Nasal polyposis in patients in the severe asthma registry

13. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

14. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study

19. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

22. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

23. Tezepelumab in patients with allergic and eosinophilic asthma

25. Pioneering a paradigm shift in asthma management: remission as a treatment goal

29. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

30. Tezepelumab in patients with allergic and eosinophilic asthma.

36. Response to biologics and clinical remission in the adult GAN severe asthma cohort.

37. German Asthma Net: Nasal polyposis in patients with severe asthma

38. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry

39. Reply to Lipworth and Chan

40. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

42. Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study.

44. Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)

45. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

47. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline

50. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

Catalog

Books, media, physical & digital resources